Background Symptomatic peripheral arterial disease (PAD) has several treatment options,
including angioplasty, stenting, exercise therapy, and bypass surgery. Atherectomy is an …

In 2014, the Society for Cardiovascular Angiography and Interventions (SCAI) published the
first Appropriate Use Criteria (AUC) for endovascular therapy (EVT) for atherosclerotic …

Guideline Summary Chronic limb-threatening ischemia (CLTI) is associated with mortality,
amputation, and impaired quality of life. These Global Vascular Guidelines (GVG) are …

Background: Peripheral artery disease (PAD) is the most underdiagnosed, underestimated
and undertreated of the atherosclerotic vascular diseases despite its poor prognosis. There …

Objectives The goal of this study was to evaluate the 5-year follow-up data of the IN. PACT
DEEP (Randomized IN. PACT Amphirion Drug-Coated Balloon [DCB] vs. Standard …

Background: Effective and durable options for infrapopliteal artery revascularization for
patients with chronic limb-threatening ischemia (CLTI) are limited. Methods: The SAVAL trial …

Endovascular revascularization has been increasingly utilized to treat patients with chronic
limb-threatening ischemia (CLTI), particularly atherosclerotic disease in the infrapopliteal …

Objective Endovascular revascularisation has become a standard approach for below knee
lesions and paclitaxel coated devices have been widely used in patients with chronic limb …

Peripheral arterial diseases comprise different clinical presentations, from cerebrovascular
disease down to lower extremity artery disease, from subclinical to disabling symptoms and …

Purpose: To report the risk of all-cause mortality after treatment with paclitaxel-coated
devices vs uncoated controls in patients with chronic limb-threatening ischemia (CLTI) …